Sotera Health Co (SHC) Shares Soar Above 1-Year High

Sotera Health Co (NASDAQ: SHC) has seen a rise in its stock price by 1.41 in relation to its previous close of 11.38. However, the company has experienced a 0.09% gain in its stock price over the last five trading sessions. Seeking Alpha reported 2024-03-03 that Sotera Health Company (SHC) Q4 2023 Earnings Call Transcript

Is It Worth Investing in Sotera Health Co (NASDAQ: SHC) Right Now?

Sotera Health Co (NASDAQ: SHC) has a price-to-earnings ratio that is above its average at 64.22x. The stock has a 36-month beta value of 2.11. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for SHC is 126.48M, and at present, short sellers hold a 9.16% of that float. On April 04, 2024, the average trading volume of SHC was 1.75M shares.

SHC’s Market Performance

The stock of Sotera Health Co (SHC) has seen a 0.09% increase in the past week, with a -20.90% drop in the past month, and a -31.10% fall in the past quarter. The volatility ratio for the week is 3.15%, and the volatility levels for the past 30 days are at 5.09% for SHC. The simple moving average for the last 20 days is -10.80% for SHC stock, with a simple moving average of -24.95% for the last 200 days.

Analysts’ Opinion of SHC

Jefferies, on the other hand, stated in their research note that they expect to see SHC reach a price target of $15.50, previously predicting the price at $15. The rating they have provided for SHC stocks is “Buy” according to the report published on March 25th, 2024.

SHC Trading at -20.76% from the 50-Day Moving Average

After a stumble in the market that brought SHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.52% of loss for the given period.

Volatility was left at 5.09%, however, over the last 30 days, the volatility rate increased by 3.15%, as shares sank -17.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.18% lower at present.

During the last 5 trading sessions, SHC rose by +0.09%, which changed the moving average for the period of 200-days by -23.27% in comparison to the 20-day moving average, which settled at $12.81. In addition, Sotera Health Co saw -31.51% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at SHC starting from WARBURG PINCUS & CO., who sale 16,594,363 shares at the price of $14.31 back on Mar 04 ’24. After this action, WARBURG PINCUS & CO. now owns 88,822,952 shares of Sotera Health Co, valued at $237,423,849 using the latest closing price.

WARBURG PINCUS & CO., the Director of Sotera Health Co, sale 16,594,363 shares at $14.31 during a trade that took place back on Mar 04 ’24, which means that WARBURG PINCUS & CO. is holding 88,822,952 shares at $237,423,849 based on the most recent closing price.

Stock Fundamentals for SHC

Current profitability levels for the company are sitting at:

  • 0.28 for the present operating margin
  • 0.54 for the gross margin

The net margin for Sotera Health Co stands at 0.05. The total capital return value is set at 0.1. Equity return is now at value 12.85, with 1.63 for asset returns.

Based on Sotera Health Co (SHC), the company’s capital structure generated 0.83 points at debt to capital in total, while cash flow to debt ratio is standing at -0.07. The debt to equity ratio resting at 5.06. The interest coverage ratio of the stock is 2.35.

Currently, EBITDA for the company is 516.81 million with net debt to EBITDA at 5.19. When we switch over and look at the enterprise to sales, we see a ratio of 5.04. The receivables turnover for the company is 5.98for trailing twelve months and the total asset turnover is 0.34. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.42.

Conclusion

To sum up, Sotera Health Co (SHC) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts